Delivery Order SPE2DB22D1017-SPE2DB25FF3GG
Award Date
1/15/25
Potential Completion Date
1/16/25
Potential Value
$1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,363.26 firm fixed-price delivery order is for the supply of Methylphenidate ER 36 mg tablets, a medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of December 11, 2024 and was awarded on December 10, 2024. This delivery order is part...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,273.72 firm-fixed-price contract is for the delivery of 36 mg methylphenidate extended-release tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., valued at up to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Methylphenidate ER 27 mg tablets, a generic medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a ceiling value of $1,662.28 and runs through February 2025. There is no set-aside designation, indicating the contract was awarded through open competition. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,261.06 firm fixed-price delivery order is for the supply of 100 tablets of 54 mg Methylphenidate ER, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of February 25, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,798.78 firm-fixed-price contract is for the delivery of 100 tablets of 27 mg extended-release methylphenidate, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a completion date of July 2, 2024. This delivery order is part of a larger...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,583 contract is for the supply of 100 tablets of Methylphenidate ER 18 mg, a medication used to treat attention deficit hyperactivity disorder (ADHD). The contract has an ultimate completion date of May 9, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $1,293.70 firm-fixed-price contract is for the delivery of 100 tablets of 27 mg methylphenidate extended-release, a drug used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is part of AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,710.36 firm fixed-price delivery order is for the supply of 4,566,250 units of methylphenidate ER 36 mg tablets, a medication commonly used to treat attention deficit hyperactivity disorder (ADHD). The contract has an ultimate completion date of October 29, 2024 and was awarded on October 28, 2024. This...
This is a $2,875.43 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The order is for 100 tablets of 36 mg extended-release methylphenidate, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December...
This federal contract award, valued at $6,192.97, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of methylphenidate hydrochloride tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD) and other conditions. The contract is a delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract...